Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 3 I, 1997, Pages 988-991

  Yates, Deborah H ^a   Worsdell, Miin ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; IPRATROPIUM BROMIDE; METHACHOLINE; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; MALE; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION; STEROID THERAPY;

EID: 0030760576     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.3.9610051     Document Type: Article

References (14)

1. Nelson, H. S. 1995. β Agonists. N. Engl. J. Med. 333:499-506.
2. British Thoracic Society. 1993. Guidelines on the management of asthma. Thorax: 48:1-24.
3. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, Q. O. Li, E. M. Flannery, D. M. Yates, et al. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391-1396.
4. Spitzer, W. O., S. Suissa, P. Ernst, R. I. Horwitz, B. Habbick, D. Cockcroft, J. F. Boivin, M. McNutt, A. S. Buist, and A. S. Rebuck. 1992. The use of beta-agonists and the risk of death and near death from asthma. N. Engl. J. Med. 326:501-506.
5. 2-agonists. Thorax 51:1051-1056.
6. 2-agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 327:1198-1203.
7. Yates, D. H., H. S. Sussman, M. Shaw, P. J. Barnes, and K. F. Chung. 1995. Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment. Am. J. Respir. Crit. Care Med. 152:1170-1174.
8. 2-agonists in asthma. N. Engl. J. Med. 327:1204-1208.
9. Cockroft, D. W., C. P. McFarland, S. A. Britto, V. A. Swystum, and B. A. Rutherford. 1993. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 432:833-837.
10. Soler, M., L. Joos, C. I. Bolliger, S. Elsasser, and A. P. Perruchoud. 1994. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine and AMP-induced bronchoconstriction. Eur. Respir. J. 7:1973-1977.
11. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
12. Ramage, L., B. J. Lipworth, C. G. Ingram, I. A. Cree, and D. P. Dhillon. 1994. Reduced protection against exercise-induced bronchoconstriction after chronic dosing with salmeterol. Respir. Med. 88:363-368.
13. Bhagat, R., S. Kalra, V. A. Swystum, and D. Cockroft. 1995. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 108: 1235-1239.
14. Yates, D. H., S. A. Kharitonov, M. Worsdell, D. M. Scott, and P. J. Barnes. 1997. Effect of regular inhaled budesonide on tolerance induced by salmeterol to the acute bronchoprotective effects of salbutamol. Am. J. Respir. Crit. Care Med. 154:1603-1607.